vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and HERITAGE COMMERCE CORP (HTBK). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $53.6M, roughly 1.4× HERITAGE COMMERCE CORP). HERITAGE COMMERCE CORP runs the higher net margin — 28.2% vs -9.6%, a 37.8% gap on every dollar of revenue. On growth, HERITAGE COMMERCE CORP posted the faster year-over-year revenue change (15.6% vs -16.8%). Over the past eight quarters, HERITAGE COMMERCE CORP's revenue compounded faster (12.8% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

The United States Chamber of Commerce (USCC) is a business association advocacy group and is the largest lobbying group in the United States. The group was founded in April 23, 1912, out of local chambers of commerce at the urging of President William Howard Taft and his secretary of commerce and labor Charles Nagel. President Taft's belief was that the "government needed to deal with a group that could speak with authority for the interests of business."

BIOX vs HTBK — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.4× larger
BIOX
$77.6M
$53.6M
HTBK
Growing faster (revenue YoY)
HTBK
HTBK
+32.5% gap
HTBK
15.6%
-16.8%
BIOX
Higher net margin
HTBK
HTBK
37.8% more per $
HTBK
28.2%
-9.6%
BIOX
Faster 2-yr revenue CAGR
HTBK
HTBK
Annualised
HTBK
12.8%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
HTBK
HTBK
Revenue
$77.6M
$53.6M
Net Profit
$-7.4M
$15.1M
Gross Margin
46.8%
Operating Margin
9.3%
41.0%
Net Margin
-9.6%
28.2%
Revenue YoY
-16.8%
15.6%
Net Profit YoY
-20.2%
42.3%
EPS (diluted)
$-0.12
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
HTBK
HTBK
Q4 25
$53.6M
Q3 25
$77.6M
$50.0M
Q2 25
$47.8M
Q1 25
$60.6M
$46.1M
Q4 24
$98.8M
$46.4M
Q3 24
$93.3M
$42.2M
Q2 24
$41.7M
Q1 24
$84.0M
$42.1M
Net Profit
BIOX
BIOX
HTBK
HTBK
Q4 25
$15.1M
Q3 25
$-7.4M
$14.7M
Q2 25
$6.4M
Q1 25
$-1.6M
$11.6M
Q4 24
$605.2K
$10.6M
Q3 24
$-6.2M
$10.5M
Q2 24
$9.2M
Q1 24
$9.8M
$10.2M
Gross Margin
BIOX
BIOX
HTBK
HTBK
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
HTBK
HTBK
Q4 25
41.0%
Q3 25
9.3%
41.1%
Q2 25
18.7%
Q1 25
1.5%
35.4%
Q4 24
14.5%
31.8%
Q3 24
2.5%
34.3%
Q2 24
31.3%
Q1 24
15.7%
34.2%
Net Margin
BIOX
BIOX
HTBK
HTBK
Q4 25
28.2%
Q3 25
-9.6%
29.4%
Q2 25
13.4%
Q1 25
-2.6%
25.2%
Q4 24
0.6%
22.9%
Q3 24
-6.6%
24.9%
Q2 24
22.1%
Q1 24
11.6%
24.1%
EPS (diluted)
BIOX
BIOX
HTBK
HTBK
Q4 25
$0.25
Q3 25
$-0.12
$0.24
Q2 25
$0.10
Q1 25
$-0.02
$0.19
Q4 24
$0.00
$0.17
Q3 24
$-0.10
$0.17
Q2 24
$0.15
Q1 24
$0.14
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
HTBK
HTBK
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$708.6M
Total Assets
$734.9M
$5.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
HTBK
HTBK
Q4 25
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Stockholders' Equity
BIOX
BIOX
HTBK
HTBK
Q4 25
$708.6M
Q3 25
$288.3M
$700.0M
Q2 25
$694.7M
Q1 25
$345.0M
$696.2M
Q4 24
$346.3M
$689.7M
Q3 24
$346.0M
$685.4M
Q2 24
$679.2M
Q1 24
$348.5M
$676.3M
Total Assets
BIOX
BIOX
HTBK
HTBK
Q4 25
$5.8B
Q3 25
$734.9M
$5.6B
Q2 25
$5.5B
Q1 25
$798.2M
$5.5B
Q4 24
$835.2M
$5.6B
Q3 24
$827.3M
$5.6B
Q2 24
$5.3B
Q1 24
$836.1M
$5.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
HTBK
HTBK
Operating Cash FlowLast quarter
$14.4M
$61.7M
Free Cash FlowOCF − Capex
$61.3M
FCF MarginFCF / Revenue
114.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
4.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
HTBK
HTBK
Q4 25
$61.7M
Q3 25
$14.4M
$18.9M
Q2 25
$8.0M
Q1 25
$23.3M
$14.8M
Q4 24
$-5.4M
$39.0M
Q3 24
$5.2M
$5.3M
Q2 24
$10.5M
Q1 24
$-17.4M
$7.3M
Free Cash Flow
BIOX
BIOX
HTBK
HTBK
Q4 25
$61.3M
Q3 25
$18.8M
Q2 25
Q1 25
Q4 24
$37.3M
Q3 24
$4.9M
Q2 24
$9.9M
Q1 24
$6.9M
FCF Margin
BIOX
BIOX
HTBK
HTBK
Q4 25
114.3%
Q3 25
37.7%
Q2 25
Q1 25
Q4 24
80.5%
Q3 24
11.6%
Q2 24
23.6%
Q1 24
16.4%
Capex Intensity
BIOX
BIOX
HTBK
HTBK
Q4 25
0.7%
Q3 25
0.1%
Q2 25
Q1 25
Q4 24
3.5%
Q3 24
1.0%
Q2 24
1.6%
Q1 24
1.0%
Cash Conversion
BIOX
BIOX
HTBK
HTBK
Q4 25
4.08×
Q3 25
1.28×
Q2 25
1.25×
Q1 25
1.28×
Q4 24
-8.85×
3.67×
Q3 24
0.50×
Q2 24
1.14×
Q1 24
-1.78×
0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons